Clinical Trials Directory

Trials / Completed

CompletedNCT04385979

Curcumin and Nanocurcumin in Oral Aphthous Ulcer

Comparison of Curcumin and NanoCurcumin in Recurrent Aphthous Stomatitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Recurrent aphthous ulcer is a painful inflammatory lesion with a high prevalence. Since the etiology is not clear, several strategies have been proposed to reduce pain and severity of its symptoms. Today, curcumin is considered as an herbal medicine with anti-inflammatory properties. Treatment or control of various inflammatory diseases has been proposed, but its low solubility in water has reduced bioavailability, while the use of nanoparticle pharmaceutical techniques has been able to solve these problems. Therefore, the aim of the present study was to evaluate the clinical efficacy of a new topical curcumin gel with nano-technology and compare it with 2% curcumin gel in patients with recurrent aphthous ulcers. This randomized clinical trial was performed on 48 patients assigned to two groups (nano-curcumin gel) and (curcumin gel). Before treatment, the size of the wound and VAS were measured. After intervention, the two variables were measured again on the fourth and seventh days , then the amount of improvement was quantitatively and qualitatively compared in the two groups and a significant level of less than 0.05 was considered.

Conditions

Interventions

TypeNameDescription
OTHERGelcontaining herbal Curcumin or NanoCurcumin

Timeline

Start date
2018-07-15
Primary completion
2019-01-01
Completion
2020-03-01
First posted
2020-05-13
Last updated
2020-05-13

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04385979. Inclusion in this directory is not an endorsement.

Curcumin and Nanocurcumin in Oral Aphthous Ulcer (NCT04385979) · Clinical Trials Directory